Article
CAR-T Therapy and CRISPR/Cas9 in Cancer Treatment
2025-06-02
Abstract excerpt
CART and CRISPR/Cas9 are two biotechnologies that have exhibited promising results in the field of cancer treatment. They are also constantly remarked for their consistent progress in clinical and preclinical trials alike. CART Therapy is a type of immunotherapy and it redirects T cells to target cancer cells. Additionally, CRISPR/Cas9 Gene Editing is a gene editing tool that enhances the capabilities of CART Ther...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7b099148-95d1-5ba5-b462-912f83b3046c
- DOI
- 10.22541/au.174890186.66745259/v1
